|
🐢
|
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.
21 auth.
G. Demetri,
M. von Mehren,
C. Blanke,
A. D. Van den Abbeele,
B. Eisenberg,
P. Roberts,
M. Heinrich,
D. Tuveson,
S. Singer,
M. Janicek,
...
J. Fletcher,
S. Silverman,
S. Silberman,
R. Capdeville,
B. Kiese,
B. Peng,
S. Dimitrijević,
B. Druker,
C. Corless,
C. Fletcher,
H. Joensuu
|
12 |
2002 |
12
🐢
|
|
🐜
|
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.
18 auth.
M. Heinrich,
C. Corless,
G. Demetri,
C. Blanke,
M. von Mehren,
H. Joensuu,
Laura S. McGreevey,
Chang-jie Chen,
A. D. Van den Abbeele,
B. Druker,
...
B. Kiese,
B. Eisenberg,
P. Roberts,
S. Singer,
C. Fletcher,
S. Silberman,
S. Dimitrijević,
J. Fletcher
|
11 |
2003 |
11
🐜
|
|
🦁
|
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.
12 auth.
H. Joensuu,
P. Roberts,
M. Sarlomo‐Rikala,
Leif C. Andersson,
P. Tervahartiala,
D. Tuveson,
...
D. Tuveson,
S. Silberman,
R. Capdeville,
S. Dimitrijević,
B. Druker,
G. Demetri
|
11 |
2001 |
11
🦁
|
|
🐜
|
FinnGen provides genetic insights from a well-phenotyped isolated population
168 auth.
M. Kurki,
J. Karjalainen,
P. Palta,
Timo P. Sipilä,
K. Kristiansson,
K. Donner,
M. Reeve,
H. Laivuori,
M. Aavikko,
M. Kaunisto,
A. Loukola,
E. Lahtela,
Hannele Mattsson,
P. Laiho,
Pietro della Briotta Parolo,
...
Arto A Lehisto,
M. Kanai,
N. Mars,
Joel T. Rämö,
T. Kiiskinen,
H. Heyne,
K. Veerapen,
S. Rüeger,
S. Lemmelä,
Wei Zhou,
S. Ruotsalainen,
K. Pärn,
T. Hiekkalinna,
Sami Koskelainen,
T. Paajanen,
Vincent Llorens,
Javier Gracia-Tabuenca,
H. Siirtola,
Kadri Reis,
A. Elnahas,
B. Sun,
Christopher N. Foley,
K. Aalto-Setälä,
Kaur Alasoo,
Mikko Arvas,
K. Auro,
Shameek Biswas,
Argyro Bizaki-Vallaskangas,
O. Carpén,
Chia-Yen Chen,
O. A. Dada,
Zhihao Ding,
M. Ehm,
K. Eklund,
M. Färkkilä,
H. Finucane,
A. Ganna,
A. Ghazal,
R. Graham,
Eric M. Green,
A. Hakanen,
M. Hautalahti,
Å. Hedman,
M. Hiltunen,
R. Hinttala,
I. Hovatta,
Xinli Hu,
A. Huertas-Vazquez,
L. Huilaja,
J. Hunkapiller,
H. Jacob,
J. Jensen,
H. Joensuu,
Sally John,
Valtteri Julkunen,
M. Jung,
J. Junttila,
K. Kaarniranta,
M. Kähönen,
Risto Kajanne,
Lila Kallio,
R. Kälviäinen,
J. Kaprio,
N. Kerimov,
J. Kettunen,
Elina Kilpeläinen,
T. Kilpi,
Katherine W. Klinger,
V. Kosma,
T. Kuopio,
Venla Kurra,
T. Laisk,
J. Laukkanen,
Nathan Lawless,
Aoxing Liu,
S. Longerich,
R. Mägi,
J. Mäkelä,
Antti A. Mäkitie,
A. Malarstig,
A. Mannermaa,
Joseph C Maranville,
A. Matakidou,
T. Meretoja,
S. Mozaffari,
Mari E. K. Niemi,
Mari E. K. Niemi,
T. Niiranen,
Christopher J O 'donnell,
M. Obeidat,
G. Okafo,
H. Ollila,
A. Palomäki,
T. Palotie,
J. Partanen,
D. Paul,
Margit K. Pelkonen,
Rion K. Pendergrass,
S. Petrovski,
A. Pitkäranta,
A. Platt,
D. Pulford,
E. Punkka,
P. Pussinen,
Neha S. Raghavan,
F. Rahimov,
D. Rajpal,
N. Renaud,
B. Riley-Gillis,
R. Rodosthenous,
Elmo Saarentaus,
A. Salminen,
Eveliina Salminen,
V. Salomaa,
J. Schleutker,
R. Serpi,
Huei-yi Shen,
R. Siegel,
K. Silander,
S. Siltanen,
S. Soini,
H. Soininen,
J. Sul,
I. Tachmazidou,
K. Tasanen,
P. Tienari,
S. Toppila-Salmi,
T. Tukiainen,
T. Tuomi,
J. Turunen,
J. Ulirsch,
Felix C. Vaura,
P. Virolainen,
J. Waring,
D. Waterworth,
Robert Yang,
M. Nelis,
A. Reigo,
A. Metspalu,
L. Milani,
T. Esko,
Caroline Fox,
A. Havulinna,
M. Perola,
S. Ripatti,
A. Jalanko,
Tarja Laitinen,
T. Mäkelä,
R. Plenge,
M. McCarthy,
H. Runz,
M. Daly,
A. Palotie
|
10 |
2023 |
10
🐜
|
|
🦁
|
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.
24 auth.
H. Joensuu,
P. Kellokumpu-Lehtinen,
P. Bono,
T. Alanko,
V. Kataja,
R. Asola,
T. Utriainen,
R. Kokko,
A. Hemminki,
M. Tarkkanen,
...
T. Turpeenniemi‐Hujanen,
S. Jyrkkiö,
M. Flander,
L. Helle,
S. Ingalsuo,
Kaisu Johansson,
A. Jääskeläinen,
M. Pajunen,
Mervi Rauhala,
J. Kaleva-Kerola,
T. Salminen,
M. Leinonen,
I. Elomaa,
J. Isola
|
10 |
2006 |
10
🦁
|
|
🐜
|
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial.
18 auth.
S. Loi,
S. Loi,
S. Michiels,
S. Michiels,
R. Salgado,
N. Sirtaine,
V. Jose,
D. Fumagalli,
P. Kellokumpu-Lehtinen,
P. Bono,
...
V. Kataja,
C. Desmedt,
M. Piccart,
S. Loibl,
C. Denkert,
M. Smyth,
H. Joensuu,
C. Sotiriou
|
10 |
2014 |
10
🐜
|
|
🐜
|
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
24 auth.
G. Demetri,
P. Reichardt,
Yoon-Koo Kang,
J. Blay,
P. Rutkowski,
H. Gelderblom,
P. Hohenberger,
M. Leahy,
M. Mehren,
H. Joensuu,
...
G. Badalamenti,
M. Blackstein,
A. Cesne,
P. Schöffski,
R. Maki,
S. Bauer,
B. Nguyen,
Jianming Xu,
T. Nishida,
J. Chung,
C. Kappeler,
I. Kuss,
D. Laurent,
P. Casali
|
10 |
2013 |
10
🐜
|
|
🦁
|
Risk stratification of patients diagnosed with gastrointestinal stromal tumor.
H. Joensuu
|
10 |
2008 |
10
🦁
|
|
🐢
|
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.
13 auth.
C. Blanke,
G. Demetri,
M. von Mehren,
M. Heinrich,
B. Eisenberg,
J. Fletcher,
C. Corless,
C. Fletcher,
P. Roberts,
Daniela Heinz,
...
Elisabeth Wehre,
Z. Nikolova,
H. Joensuu
|
9 |
2008 |
9
🐢
|
|
🐜
|
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
63 auth.
P. Casali,
N. Abecassis,
S. Bauer,
R. Biagini,
S. Bielack,
S. Bonvalot,
I. Boukovinas,
J. Bovée,
T. Brodowicz,
J. Broto,
A. Buonadonna,
E. Álava,
A. Tos,
X. D. Muro,
P. Dileo,
...
M. Eriksson,
A. Fedenko,
V. Ferraresi,
A. Ferrari,
S. Ferrari,
A. Frezza,
S. Gasperoni,
H. Gelderblom,
T. Gil,
G. Grignani,
A. Gronchi,
R. Haas,
A. Hannu,
B. Hassan,
P. Hohenberger,
R. Issels,
H. Joensuu,
Robin L. Jones,
I. Judson,
P. Jutte,
S. Kaal,
B. Kasper,
K. Kopeckova,
D. Krákorová,
A. Cesne,
I. Lugowska,
O. Merimsky,
M. Montemurro,
M. Pantaleo,
R. Piana,
P. Picci,
S. Piperno-Neumann,
A. L. Pousa,
P. Reichardt,
M. Robinson,
P. Rutkowski,
A. Safwat,
P. Schöffski,
S. Sleijfer,
S. Stacchiotti,
K. Hall,
M. Unk,
F. Coevorden,
W. V. D. Graaf,
J. Whelan,
E. Wardelmann,
O. Zaikova,
J. Blay
|
9 |
2018 |
9
🐜
|
|
🦁
|
One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.
23 auth.
H. Joensuu,
M. Eriksson,
K. Sundby Hall,
J. Hartmann,
D. Pink,
J. Schütte,
G. Ramadori,
P. Hohenberger,
J. Duyster,
S. Al-Batran,
...
M. Schlemmer,
S. Bauer,
E. Wardelmann,
M. Sarlomo‐Rikala,
B. Nilsson,
H. Sihto,
O. Monge,
P. Bono,
R. Kallio,
Aki Vehtari,
M. Leinonen,
T. Alvegård,
P. Reichardt
|
9 |
2012 |
9
🦁
|
|
🦁
|
Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.
18 auth.
H. Joensuu,
Aki Vehtari,
J. Riihimäki,
T. Nishida,
S. Steigen,
P. Brabec,
L. Plank,
B. Nilsson,
C. Cirilli,
C. Braconi,
...
A. Bordoni,
M. K. Magnússon,
Z. Linke,
J. Šufliarský,
M. Federico,
J. Jónasson,
A. D. Dei Tos,
P. Rutkowski
|
9 |
2012 |
9
🦁
|
|
🐜
|
Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.
8 auth.
A. Ristimäki,
A. Sivula,
J. Lundin,
M. Lundin,
T. Salminen,
C. Haglund,
...
H. Joensuu,
J. Isola
|
9 |
2002 |
9
🐜
|
|
🐜
|
Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.
14 auth.
M. Heinrich,
C. Corless,
C. Blanke,
G. Demetri,
H. Joensuu,
P. Roberts,
B. Eisenberg,
M. von Mehren,
C. Fletcher,
K. Sandau,
...
K. McDougall,
W. Ou,
Chang-jie Chen,
J. Fletcher
|
9 |
2006 |
9
🐜
|
